EUVIMEDEUVIMED entdecken
Crossref

Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials

Lina M Montoya iD, Elvin H Geng, Harriet F Adhiambo, Eliud Akama, Starley B Shade, Assurah Elly, Thomas Odeny, Maya L Petersen

Statistics in Medicine · 2026-06 · 45 (13-14)

DOI: 10.1002/sim.70634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 10.06.2026. Verfasst von Lina M Montoya und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Data Science and Society, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Cost-Benefit Analysis, Randomized Controlled Trials as Topic. Die Arbeit nennt 45 Literaturangaben. Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sequential multiple assignment randomized trials (SMARTs) have grown in popularity in recent years, and many of their study protocols propose conducting a cost‐effectiveness analysis of the adaptive strategies embedded within them. The cost‐effectiveness of these regimes is often proposed to be assessed using incremental cost‐effectiveness ratios (ICERs). In this paper, we present an estimation and inference procedure for such cost‐effectiveness measures for the embedded dynamic treatment regimes within a SMART design. In particular, we describe a targeted maximum likelihood estimator for the ICER of a SMART's embedded regimes with influence curve‐based inference. We illustrate the performance of these methods using simulations. Throughout, we use as illustration a cost‐effectiveness analysis for the Adaptive Strategies for Preventing and Treating Lapses of Retention in HIV Care (ADAPT‐R; NCT02338739) trial, presenting estimated ICERs (with inference) for embedded regimes aimed at increasing HIV care adherence. This manuscript is one of the first to present cost‐effectiveness analysis results from a SMART.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Effectiveness AnalysisCost-Benefit AnalysisRandomized Controlled Trials as TopicHumansHIV InfectionsLikelihood FunctionsComputer SimulationAnti-HIV Agents

Stichwörter der Autor:innen

cost‐effectiveness analysisincremental cost‐effectiveness ratiosequential multiple assignment randomized trialtargeted maximum likelihood estimation

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • School of Data Science and Society, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
  • Department of Child, Family, and Population Health Nursing, University of Washington, Seattle, WA, USA.
  • Department of Global Health, University of Washington, Seattle, WA, USA.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.

ORCID-Profile: Lina M Montoya

Förderung

  • NIMH NIH HHS

Zitieren

APA

Montoya, L. M., Geng, E. H., Adhiambo, H. F., Akama, E., Shade, S. B., Elly, A., Odeny, T., & Petersen, M. L. (2026). Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials. Statistics in Medicine, 45(13-14). https://doi.org/10.1002/sim.70634

Vancouver

Montoya LM, Geng EH, Adhiambo HF, Akama E, Shade SB, Elly A, et al. Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials. Statistics in Medicine. 2026;45(13-14). doi:10.1002/sim.70634

BibTeX
@article{Montoya2026,
  author = {Montoya, Lina M and Geng, Elvin H and Adhiambo, Harriet F and Akama, Eliud and Shade, Starley B and Elly, Assurah and Odeny, Thomas and Petersen, Maya L},
  title = {Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {13-14},
  doi = {10.1002/sim.70634}
}
Kostenlos starten →